ECT | g.app

ECT
Ecarin Clotting Time

Point-of-Care-Test

Normalwert*: 23 bis 29 sec.

Anwendung*:
Point-of-Care-Test zur Evalulierung der Wirkung von Thrombin-Inhibitoren (Dabigatran, Argatroban und Bivalirudin).

* Weitere Informationen siehe Literatur

POCT in STATPEARLS aktuell
Artikel wird regelmäßig aktualisiert.
Practical-Hemostasis.com
... Normalwert
Heubner ANESTHESIOLOGY 2024
Monitoring of Argatroban in Critically Ill Patients: A Prospective Study Comparing Activated Partial Thromboplastin Time, Point-of-Care Viscoelastic Testing with Ecarin Clotting Time and Diluted Thrombin Time to Mass Spectrometry
Solbeck SCAND J CLIN LAB INVEST 2018
The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG®), Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT)
Case Reports
PubMed-Suche

ECT Ecarin Clotting Time

Point-of-Care-Test

Normalwert*: 23 bis 29 sec.

Anwendung*:
Point-of-Care-Test zur Evalulierung der Wirkung von Thrombin-Inhibitoren (Dabigatran, Argatroban und Bivalirudin).

* Weitere Informationen über Internet-Links zur Literatur.

ECT

POCT
in STATPEARLS aktuell
Artikel wird regelmäßig aktualisiert.
Practical-Hemostasis.com
... Normalwert
Quellen chronologisch
Heubner ANESTHESIOLOGY 2024
Monitoring of Argatroban in Critically Ill Patients: A Prospective Study Comparing Activated Partial Thromboplastin Time, Point-of-Care Viscoelastic Testing with Ecarin Clotting Time and Diluted Thrombin Time to Mass Spectrometry
Solbeck SCAND J CLIN LAB INVEST 2018
The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG®), Hemoclot Thrombin Inhibitor (HTI) assay and Ecarin Clotting Time (ECT)
Case Reports
PubMed-Suche